These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 23858581)
21. [Child neuropsychiatric perspectives can contribute to understanding of social disadvantage]. Gillberg C Lakartidningen; 2001 Apr; 98(17):2032-4. PubMed ID: 11374232 [TBL] [Abstract][Full Text] [Related]
24. [Medico-social problems in women with oncological diseases]. Dzhorgova R; Dimitrova D; Netsova V Akush Ginekol (Sofiia); 2007; 46 Suppl 4():35-6. PubMed ID: 19705697 [No Abstract] [Full Text] [Related]
25. A behavior rating scale for assessing improvement in behaviorally deviant children: a preliminary investigation. Kupietz S; Bialer I; Winsberg HG Am J Psychiatry; 1972 May; 128(11):1432-6. PubMed ID: 5020193 [No Abstract] [Full Text] [Related]
26. Body dysmorphic disorder. Albertini RS; Phillips KA; Guevremont D J Am Acad Child Adolesc Psychiatry; 1996 Nov; 35(11):1425-6. PubMed ID: 8936908 [No Abstract] [Full Text] [Related]
27. Manic-depressive illness in children and effect of treatment with lithium carbonate. Annell AL Acta Paedopsychiatr; 1969; 36(8):292-301. PubMed ID: 4904303 [No Abstract] [Full Text] [Related]
28. Risperidone improves behavior in children with autism. Caicedo C; Williams SH J Fam Pract; 2002 Nov; 51(11):915. PubMed ID: 12485538 [No Abstract] [Full Text] [Related]
29. Primary prevention. Kessler M; Albee GW Annu Rev Psychol; 1975; 26():557-91. PubMed ID: 1094932 [No Abstract] [Full Text] [Related]
31. [Behavior problems in children]. Dubois B Lille Med; 1972 Jan; 17():Suppl 1:22-3. PubMed ID: 5026562 [No Abstract] [Full Text] [Related]
32. Trifluoperazine in children and adolescents with marked behavior problems. Smith SW Am J Psychiatry; 1965 Dec; 122(6):702-3. PubMed ID: 5843663 [No Abstract] [Full Text] [Related]
33. Remission From Behavioral Dysregulation in a Child With PTSD After Receiving Procedural Ketamine. Donoghue AC; Roback MG; Cullen KR Pediatrics; 2015 Sep; 136(3):e694-6. PubMed ID: 26260717 [TBL] [Abstract][Full Text] [Related]
34. [Behavior disorders in children and adolescents: what is medicine's responsibility?]. Nau JY Rev Med Suisse; 2005 Nov; 1(39):2553. PubMed ID: 16323739 [No Abstract] [Full Text] [Related]
35. [Use of pimozide in child psychiatry]. Debray P; Messerschmitt P; Lonchamp D; Herbault M Nouv Presse Med; 1972 Dec; 1(43):2917-8. PubMed ID: 4119351 [No Abstract] [Full Text] [Related]
36. A new drug for behavior problems in children: a preliminary report. Baldwin RW; Kenny TJ; Badie D Curr Ther Res Clin Exp; 1967 Sep; 9(9):457-61. PubMed ID: 4963978 [No Abstract] [Full Text] [Related]
38. Given the multifaceted nature of ADHD, namely its physiologic, cognitive, psychological, and behavioral manifestations, multimodal approaches to treatment are advocated. Introduction. Markowitz JS; Patrick KS J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S37-8. PubMed ID: 18480675 [No Abstract] [Full Text] [Related]
39. Explorations in a proposed national policy for children and families. Chung WS; Pardeck JT Adolescence; 1997; 32(126):429-36. PubMed ID: 9179338 [TBL] [Abstract][Full Text] [Related]
40. Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia. Van der Heijden KB; Smits MG; Van Someren EJ; Ridderinkhof KR; Gunning WB J Am Acad Child Adolesc Psychiatry; 2007 Feb; 46(2):233-41. PubMed ID: 17242627 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]